fls.txt
Certain statements in this section and other parts of this Quarterly Report on Form 10-Q may constitute "forward-looking statements" within the meaning of the federal securities laws and are entitled to the safe-harbor provisions of the PSLRA.
Such statements can be identified by the use of forward-looking terminology such as "believes," "expects," "may," "estimates," "will," "should," "plans" or "anticipates" or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategy, although not all forward-looking statements contain such terms.


item2.txt
Cautionary Statement Regarding Forward-Looking Statements Under the Private Securities Litigation Reform Act of 1995 (“PSLRA”).
Founded in 1927, Littelfuse is a global manufacturer of leading technologies in circuit protection, power control and sensing.
The Company estimates the restructuring costs associated with this plant closure to be approximately $5.0 million to $7.0 million.
Net cash provided by operating activities was $30.9 million for the three months ended March 30, 2019 as compared to $69.3 million for the three months ended March 31, 2018.
In addition, there were $0.8 million of employee termination costs and $0.1 million of acquisition-related expenses for other contemplated acquisitions.
Operating margins increased from 9.0% in the first quarter of 2018 to 15.0% in the first quarter of 2019 driven by factors mentioned above.
Net sales increased $1.0 million, or 0.4%, in the first quarter of 2019 compared to the first quarter of 2018 primarily due to $10.2 million increase in the semiconductor business due to the IXYS acquisition completed on January 17, 2018, partially offset by unfavorable foreign currency impact of $5.3 million and lower electronics products volume.
Net sales decreased $6.5 million, or 3.6%, in the first quarter of 2019 compared to the first quarter of 2018.
Net sales decreased $5.1 million, or 5.1%, in the first quarter of 2019 compared to the first quarter of 2018.
The Company has historically supported its liquidity needs through cash flows from operations.
Management expects that the Company’s (i) current level of cash, cash equivalents, and marketable securities, (ii) current and forecasted cash flows from operations, (iii) availability under existing funding arrangements, and (iv) access to capital in the capital markets will provide sufficient funds to support the Company’s operations, capital expenditures, investments, and debt obligations on both a short-term and long-term basis.
Term Loans may be made in up to two advances.
The first advance of $125.0 million occurred on October 13, 2017 and the second advance of $75.0 million occurred on January 16, 2018.
Outstanding borrowings under the Credit Agreement bear interest, at the Company’s option, at either LIBOR, fixed for interest periods of one, two, three or six-month periods, plus 1.00% to 2.00%, or at the bank’s Base Rate, as defined, plus 0.00% to 1.00%, based upon the Company’s Consolidated Leverage Ratio, as defined.
The credit agreement includes representations, covenants and events of default that are customary for financing transactions of this nature.
Further information regarding the Company’s credit agreement is provided in Note 9, Debt, of the Notes to the Condensed Consolidated Financial Statements included in this Quarterly Report.
On December 8, 2016, the Company entered into a Note Purchase Agreement, pursuant to which the Company issued and sold €212 million aggregate principal amount of senior notes in two series.
occurred on December 8, 2016 for €117 million in aggregate amount of 1.14% Senior Notes, Series A, due December 8, 2023 (“Euro Senior Notes, Series A due 2023”), and €95 million in aggregate amount of 1.83% Senior Notes, Series B due December 8, 2028 (“Euro Senior Notes, Series B due 2028”) (together, the “Euro Senior Notes”).
On December 8, 2016, the Company entered into a Note Purchase Agreement, pursuant to which the Company issued and sold $125 million aggregate principal amount of senior notes in two series.
Senior Notes, Series A due 2022”), and $100 million in aggregate principal amount of 3.74% Senior Notes, Series B, due February 15, 2027 (“U.S.
Interest on the U.S. Senior Notes due 2022 and 2027 is payable semiannually on February 15 and August 15, commencing August 15, 2017.
On November 15, 2017, the Company entered into a Note Purchase Agreement pursuant to which the Company issued and sold $175 million in aggregate principal amount of senior notes in two series.
On January 16, 2018, $50 million aggregate principal amount of 3.48% Senior Notes, Series A, due February 15, 2025 (“U.S.
Senior Notes, Series A due 2025”) and $125 million in aggregate principal amount of 3.78% Senior Notes, Series B, due February 15, 2030 (“U.S.
Further information regarding the Company’s Senior Notes is provided in Note 9, Debt, of the Notes to the Condensed Consolidated Financial Statements included in this Quarterly Report.
Operating cash inflows are largely attributable to sales of the Company’s products.


item3.txt



item4.txt
In connection with the preparation of this report, management, under the supervision and with the participation of the Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of March 30, 2019.


part2.txt
The Company’s Board of Directors authorized the repurchase of up to 1,000,000 shares of the Company’s common stock under a program for the period May 1, 2018 to April 30, 2019.


